http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26a7ffededb3029d940e5b019b956755
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Chen |
| name | Wendy Y. Chen Wendy Y Chen |
| given-name | Wendy Y. Wendy Y |
| organization-name | Dana Farber Cancer Institute, Boston, Massachusetts Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, MA Michelle D. Holmes, Susan E. Hankinson, Rulla M. Tamimi, and Wendy Y. Chen, Brigham and Women’s Hospital; Michelle D. Holmes and Rulla M. Tamimi, Harvard T.H. Chan School of Public Health; Wendy Y. Chen, Dana-Farber Cancer Institute, Boston; and Jun Wang and Susan E. Hankinson, University of Massachusetts Amherst, Amherst, MA. Harvard Medical School , Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center , Boston, MA, USA from the Brigham and Women’s Hospital/Massachusetts General Hospital Joint Nephrology Fellowship and Brigham and Women’s Hospital Endocrinology Fellowship Programs Department of Medical Oncology, Dana Farber Cancer Institute Harvard Medical School, Harvard University Boston Massachusetts USA From the Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Department of Medical Oncology, Dana-Farber Cancer Institute; and Departments of Epidemiology and Biostatistics, Harvard School of Public Health, Boston, MA. 1Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; 6Dana-Farber Cancer Institute, Boston, Massachusetts. 1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital;; 2Department of Adult Oncology, Dana-Farber Cancer Institute; Departments of Department of Medical Oncology Dana Farber Cancer Institute Boston MA USA; Harvard Medical School Boston MA USA 3Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; 6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Channing Division of Network Medicine Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA 02115; Department of Medical Oncology Dana Farber Cancer Institute Boston MA Channing Division of Network Medicine, Department of Medicine; Brigham and Women's Hospital, Harvard Medical School; Boston MA; Department of Medical Oncology; Dana Farber Cancer Institute; Boston MA 3Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; 4Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, and Dana Farber Cancer Institute, 181 Longwood Avenue, Boston, MA 02115, USA. Authors' Affiliations: 1Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; 2Division of Research, Kaiser Permanente Northern California, Oakland; 3Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, California; 4Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 6Shanghai Center for Disease Control and Prevention, Shanghai, China; Authors' Affiliations: 1Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; 2Division of Research, Kaiser Permanente Northern California, Oakland; 3Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, California; 4Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 6Shanghai Center for Disease Control and Prevention, Shanghai, China Channing Division of Network Medicine, Brigham and Women’s Hospital, and Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Dana Farber Cancer Institute, Boston, MA 4Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA; and; 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA From the Channing Laboratory, Department of Medicine, Brigham & Women's Hospital, and Harvard Medical School; and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA From the Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Channing Laboratory, Boston, MA Channing Division of Network Medicine Brigham and Women's Hospital Boston MA USA; Dana Farber Cancer Institute Department of Medical Oncology Boston MA USA Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 2Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Authors' Affiliations: 1Division of Research, Kaiser Permanente, Oakland, California; 2Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; 3Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, California; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Authors' Affiliations: 1Division of Research, Kaiser Permanente, Oakland, California; 2Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; 3Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, California; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; 3Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Channing Division of Network Medicine Brigham & Women's Hospital Boston Massachusetts USA; Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA Michelle D. Holmes, Channing Division of Network Medicine and Harvard T. H. Chan School of Public Health, Boston, MA; Jun Wang, University of Massachusetts Amherst, Amherst, MA; Susan E. Hankinson, Channing Division of Network Medicine, Boston and University of Massachusetts Amherst, Amherst, MA; Rulla M. Tamimi, Channing Division of Network Medicine and Harvard T. H. Chan School of Public Health, Boston, MA; and Wendy Y. Chen, Channing Division of Network Medicine and Dana-Farber Cancer Institute,... Authors' Affiliations: 1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, California; 3Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; Authors' Affiliations: 1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, California; 3Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and 5Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX Channing Division of Network Medicine Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts; Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts Channing Division of Network Medicine, Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA; Department of Medical Oncology Dana‐Farber Cancer Institute Boston MA Dana-Farber Cancer Institute, Boston MA; and From the Channing Laboratory, Department of Medicine, Brigham & Women's Hospital, and Harvard Medical School; Department of Medical Oncology, Dana Farber Cancer Institute; and Department of Health and Social Behavior and Department of Epidemiology, Harvard School of Public Health, Boston, MA Channing Division of Network Medicine Brigham and Women's Hospital Boston Massachusetts; Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts Channing Division of Network Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA 02115; Department of Medical Oncology Dana Farber Cancer Institute Boston MA 02115 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 2Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School;; 3Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Authors' Affiliations: 1Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, 2Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee; 3Shanghai Municipal Center for Disease Control and Prevention, Shanghai, P.R., China; 4Department of Epidemiology, Shanghai Cancer Institute, Shanghai, PR China; 5Channing Laboratory, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School; 6Department of Medical Oncology, Dana Farber Cancer Institute; and 7Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Authors' Affiliations: 1Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, 2Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee; 3Shanghai Municipal Center for Disease Control and Prevention, Shanghai, P.R., China; 4Department of Epidemiology, Shanghai Cancer Institute, Shanghai, PR China; 5Channing Laboratory, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School; 6Department of Medical Oncology, Dana Farber Cancer Institute; and 7Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts Channing Division of Network Medicine, Brigham and Women's Hospital Boston Massachusetts; Department of Medical Oncology Dana Farber Cancer Institute Boston Massachusetts 2Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; 6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 4Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; 7Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts;; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts |
Incoming Links
Showing number of triples: 1 to 175 of 175.